More PRNewswire
View Older Stories View Newer Stories-
HNO International Targets NASDAQ Uplist and Capital Raise with Respected Investment Banking Firm
-
NEXE Innovations Completes Delivery of Previously Announced Purchase Order to ecoBeans Coffee
-
PrideStaff's GoFundMe Campaign Raises Thousands to Help Asheville Employees Rebuild After Hurricane Helene
-
Hycroft Once Again Drills Best Hole Ever
-
U.S. News & World Report Unveils the 2025 Best Jobs
-
ASHFORD HOSPITALITY TRUST ANNOUNCES SALE OF THE COURTYARD BOSTON DOWNTOWN
-
From Organic Fields to Coffee Mugs: New Organic Valley® Creamers Made with Oats Sourced Directly from Organic Family Farms in the Heartland
-
AVIATOR NATION LAUNCHES EXCLUSIVE MERCHANDISE COLLECTION FOR THE 2025 COLLEGE FOOTBALL PLAYOFF NATIONAL CHAMPIONSHIP
-
Truv Integrates with Freddie Mac AIM Check API
-
Corelight Enhances Network Visibility and Detection Coverage with Insights from Microsoft Defender
-
AT J.P. MORGAN HEALTHCARE CONFERENCE, 120/80 GROUP PROJECTS ANOTHER YEAR OF RAPID GROWTH IN HELPING TO ACCELERATE THE CONVERGENCE OF AI AND HEALTH
-
International Paper to Release Fourth-Quarter and Full-Year 2024 Earnings on January 30, 2025
-
BCN Expands C-Suite with Strategic Promotions to Drive Continued Growth and Innovation
-
Scale Computing Delivers Reliable, Cost Effective, Simple, and Scalable IT Infrastructure to Educational Institutions
-
Zensai Executives Join Dynamic Speaker Roster of AI Luminaries and Innovators from Amazon, OpenAI, Snowflake, and More at HumanX 2025
-
Floss Ring Announces Innovative Flossing Solution: Never Forget To Floss Again!
-
Bug Off Pest Control Center of New York City to Supply New York City with Evolve™
-
Palistar Capital Announces Combination of U.S. Wireless Assets
-
Black Duck's BSIMM15 Report Highlights How Companies Are Tackling Security Risk in AI and Software Supply Chains
-
ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND
-
PIZZA LOVERS, REJOICE! CHEEZ-IT® FIRES UP NEW PIZZA-INSPIRED FLAVORS
-
IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award
-
Velotix Unveils Velotix One: From Data Chaos to Clarity
-
Nano Labs Announces Partnership with the Inaugural Presidential Crypto Ball
-
Attention Oregonians! Alaska Airlines announces three new nonstops around the state
-
Ascend Analytics Publishes Inaugural Energy Transition Predictions
-
Prodigy Processing Solutions Announces Strategic Partnership with inTEST Thermal Solutions
-
FIRST RESERVE ANNOUNCES THREE PROMOTIONS
-
The Fitness, Health and Wellness Community Unite for a Month-Long Initiative to Give Back and 'Get Fit for No Kid Hungry'
-
College of Eastern Idaho Launches myCEI Digital Platform to Enhance Campus Connectivity and Student Engagement
-
AU10TIX Prevents an Estimated $7.5 Billion of Identity Fraud in 2024
-
Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge
-
Core BTS Named a Best Place to Work in Technology for Second Consecutive Year
-
Fuel & Elevate's Hemp Drinks Sweep America's Best Awards!
-
YouScience Releases New Book 'Preparing Tomorrow's Workforce' to Address Critical Career Navigation Skills Gap
-
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
-
Ascend Wellness Holdings Closes $15 Million Private Placement of Senior Secured Notes
-
SEI Bolsters Global Leadership with Key Appointments in Luxembourg
-
OpenEnvoy Partners with Schreiber Foods to Launch Autonomous Finance
-
Cognex Strengthens Market Leadership in Industrial Barcode Reading with Two New AI-Powered Products
-
Leidos Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call for February 11, 2025, at 8 a.m. (ET)
-
Asymbl Announces Vision for the Future of Work, Rebranding, New Solutions, and Asymbl Intelligence
-
New research from Sure reveals striking digital divide of insurance preferences between younger and older consumers
-
Report Confirms ALDI Offers the Lowest Prices of Any National Grocery Store, Saving Shoppers $8.3 Billion Per Year
-
LANDSEA HOMES INTRODUCES NEW FEATURES TO ITS INDUSTRY-LEADING HIGH PERFORMANCE HOMES
-
The Leukemia & Lymphoma Society Names Lore Gruenbaum, Ph.D., New Chief Scientific Officer
-
New Survey: Parent Demand for K-12 School Choice Remains Robust in Post-COVID America
-
REI Systems Secures $3.8M NASA PETS Contract to Drive Innovation
-
ButterflyMX Secures Significant Growth Equity Investment from FTV Capital
-
Protiviti Adopts Ardoq for Internal Use, Fostering Increased Efficiency, Transparency, and Agility
